In the Peto et al study (Peto et al, 1999), BRCA1 and BRCA2 were estimated to account for 1.9% and 2.2% of unselected breast cancers diagnosed between ages 36 and 45 years. This evidence concerns the gene BRCA2 and breast cancer.